ABVC BioPharma

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ABVC BioPharma and other ETFs, options, and stocks.

About ABVC

ABVC BioPharma, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new drugs and medical devices. The firm's product pipeline includes ABV-1501, which is a combination therapy for triple negative breast cancer, ABV-1504, which is a botanical reuptake inhibitor that targets norepinephrine, ABV-1505 for treating attention deficit hyperactivity disorder, ABV-1702 to treat myelodysplastic syndromes, ABV-1703 for Pancreatic Cancer, ABV-1601 for treating depression in cancer patients, ABV-1701, which is a vitreous substitute for vitrectomy, ABV-2001, and ABV-2002. 

CEO
Howard Doong
CEOHoward Doong
Employees
30
Employees30
Headquarters
Fremont, California
HeadquartersFremont, California
Founded
1990
Founded1990
Employees
30
Employees30

ABVC Key Statistics

Market cap
30.25M
Market cap30.25M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
88.54K
Average volume88.54K
High today
$1.04
High today$1.04
Low today
$0.8101
Low today$0.8101
Open price
$0.85
Open price$0.85
Volume
96.78K
Volume96.78K
52 Week high
$11.69
52 Week high$11.69
52 Week low
$0.50
52 Week low$0.50

ABVC Earnings

-$0.31
-$0.21
-$0.10
$0.00
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, After Hours
ActualExpected Nov 14, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.